How do you manage TTFields for a patient with glioblastoma in the setting of disease progression?
Do you routinely discontinue the device or continue if they are otherwise tolerating the treatment well?
Community PollStarted
When managing a patient with progressive glioblastoma on TTF therapy, do you:
128 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Neurology · Wake Forest School of Medicine
Answered on
Continuation of Tumor Treating Field (TTF) therapy at progression is an individualized decision for each patient.
In the EF-14 trial upon which TTF was approved for newly diagnosed GBM after chemoradiotherapy, TTF was able to be continued until second progression. In this study, 18% more patients wer...
Join for free or sign in to see the full answer